CLINICAL_TRIALS
trial_result
· 2010-10-08
Clinical Trial Update: Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325 [Phase 2]
Summary
This update reports Phase 2 proof-of-concept results for AZD7325 in patients with generalized anxiety disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Anxiety Disorders | Phase 2 | Status: COMPLETED | Results posted: 2010-10-08